139 related articles for article (PubMed ID: 25537548)
21. Early prediction of phenotypic severity in Citrullinemia Type 1.
Zielonka M; Kölker S; Gleich F; Stützenberger N; Nagamani SCS; Gropman AL; Hoffmann GF; Garbade SF; Posset R;
Ann Clin Transl Neurol; 2019 Sep; 6(9):1858-1871. PubMed ID: 31469252
[TBL] [Abstract][Full Text] [Related]
22. Mutations and polymorphisms in the human argininosuccinate synthetase (ASS1) gene.
Engel K; Höhne W; Häberle J
Hum Mutat; 2009 Mar; 30(3):300-7. PubMed ID: 19006241
[TBL] [Abstract][Full Text] [Related]
23. Detection of homozygous genotypes for a putatively lethal recessive mutation in the porcine argininosuccinate synthase 1 (ASS1) gene.
Mármol-Sánchez E; Luigi-Sierra MG; Quintanilla R; Amills M
Anim Genet; 2020 Feb; 51(1):106-110. PubMed ID: 31729055
[TBL] [Abstract][Full Text] [Related]
24. PRMT7 Interacts with ASS1 and Citrullinemia Mutations Disrupt the Interaction.
Verma M; Charles RCM; Chakrapani B; Coumar MS; Govindaraju G; Rajavelu A; Chavali S; Dhayalan A
J Mol Biol; 2017 Jul; 429(15):2278-2289. PubMed ID: 28587924
[TBL] [Abstract][Full Text] [Related]
25. Naturally-occurring spinosyn A and its derivatives function as argininosuccinate synthase activator and tumor inhibitor.
Zou Z; Hu X; Luo T; Ming Z; Chen X; Xia L; Luo W; Li J; Xu N; Chen L; Cao D; Wen M; Kong F; Peng K; Xie Y; Li X; Ma D; Yang C; Chen C; Yi W; Liu O; Liu S; Luo J; Luo Z
Nat Commun; 2021 Apr; 12(1):2263. PubMed ID: 33859183
[TBL] [Abstract][Full Text] [Related]
26. Argininosuccinate synthetase deficiency: mutation analysis in 3 Thai patients.
Wasant P; Viprakasit V; Srisomsap C; Liammongkolkul S; Ratanarak P; Sathienkijakanchai A; Svasti J
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):757-61. PubMed ID: 16124451
[TBL] [Abstract][Full Text] [Related]
27. Phenotype and genotype heterogeneity in Mediterranean citrullinemia.
Vilaseca MA; Kobayashi K; Briones P; Lambruschini N; Campistol J; Tabata A; Alomar A; Rodès M; Lluch M; Saheki T
Mol Genet Metab; 2001 Nov; 74(3):396-8. PubMed ID: 11708871
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of Korean patients with citrullinemia.
Hong KM; Shin CH; Choi YB; Song WK; Lee SD; Rhee KI; Jang P; Pak GS; Kim JK; Paik MK; Hahn SH
Mol Cells; 2000 Aug; 10(4):465-8. PubMed ID: 10987146
[TBL] [Abstract][Full Text] [Related]
29. Identification of Novel Mutations in Chinese Infants With Citrullinemia.
Cheng Z; He X; Zou F; Xu ZE; Li C; Liu H; Miao J
Front Genet; 2022; 13():783799. PubMed ID: 35309121
[TBL] [Abstract][Full Text] [Related]
30. Mutations and DNA diagnoses of classical citrullinemia.
Kakinoki H; Kobayashi K; Terazono H; Nagata Y; Saheki T
Hum Mutat; 1997; 9(3):250-9. PubMed ID: 9090528
[TBL] [Abstract][Full Text] [Related]
31. Improved standards for prenatal diagnosis of citrullinemia.
Miller MJ; Soler-Alfonso CR; Grund JE; Fang P; Sun Q; Elsea SH; Sutton VR
Mol Genet Metab; 2014 Jul; 112(3):205-9. PubMed ID: 24889030
[TBL] [Abstract][Full Text] [Related]
32. Identification of 16 novel mutations in the argininosuccinate synthetase gene and genotype-phenotype correlation in 38 classical citrullinemia patients.
Gao HZ; Kobayashi K; Tabata A; Tsuge H; Iijima M; Yasuda T; Kalkanoglu HS; Dursun A; Tokatli A; Coskun T; Trefz FK; Skladal D; Mandel H; Seidel J; Kodama S; Shirane S; Ichida T; Makino S; Yoshino M; Kang JH; Mizuguchi M; Barshop BA; Fuchinoue S; Seneca S; Zeesman S; Knerr I; Rodés M; Wasant P; Yoshida I; De Meirleir L; Abdul Jalil M; Begum L; Horiuchi M; Katunuma N; Nakagawa S; Saheki T
Hum Mutat; 2003 Jul; 22(1):24-34. PubMed ID: 12815590
[TBL] [Abstract][Full Text] [Related]
33. Transient fulminant liver failure as an initial presentation in citrullinemia type I.
Faghfoury H; Baruteau J; de Baulny HO; Häberle J; Schulze A
Mol Genet Metab; 2011 Apr; 102(4):413-7. PubMed ID: 21227727
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic targeting of argininosuccinate synthase 1 (ASS1)-deficient pulmonary fibrosis.
Li JM; Yang DC; Oldham J; Linderholm A; Zhang J; Liu J; Kenyon NJ; Chen CH
Mol Ther; 2021 Apr; 29(4):1487-1500. PubMed ID: 33508432
[TBL] [Abstract][Full Text] [Related]
35. The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia.
Dimmock DP; Trapane P; Feigenbaum A; Keegan CE; Cederbaum S; Gibson J; Gambello MJ; Vaux K; Ward P; Rice GM; Wolff JA; O'Brien WE; Fang P
Am J Med Genet A; 2008 Nov; 146A(22):2885-90. PubMed ID: 18925679
[TBL] [Abstract][Full Text] [Related]
36. Citrullinemia type I, classical variant. Identification of ASS-p~G390R (c.1168G>A) mutation in families of a limited geographic area of Argentina: a possible population cluster.
Laróvere LE; Angaroni CJ; Antonozzi SL; Bezard MB; Shimohama M; de Kremer RD
Clin Biochem; 2009 Jul; 42(10-11):1166-8. PubMed ID: 19358837
[TBL] [Abstract][Full Text] [Related]
37. Mild citrullinemia in Caucasians is an allelic variant of argininosuccinate synthetase deficiency (citrullinemia type 1).
Häberle J; Pauli S; Schmidt E; Schulze-Eilfing B; Berning C; Koch HG
Mol Genet Metab; 2003 Nov; 80(3):302-6. PubMed ID: 14680976
[TBL] [Abstract][Full Text] [Related]
38. Citrullinemia type 1: genetic diagnosis and prenatal diagnosis in subsequent pregnancy.
Karthikeyan G; Jagadeesh S; Seshadri S; Häberle J
Indian Pediatr; 2013 Oct; 50(10):965-6. PubMed ID: 24222285
[TBL] [Abstract][Full Text] [Related]
39. Citrullinaemia type I: a common mutation in the Pacific Island population.
Glamuzina E; Marquis-Nicholson R; Knoll D; Love DR; Wilson C
J Paediatr Child Health; 2011 May; 47(5):262-5. PubMed ID: 21244552
[TBL] [Abstract][Full Text] [Related]
40. Diagnosis of citrullinemia type 1 carriage after identification of mild citrullinemia on neonatal screening.
Sugawara D; Taniguchi S; Sato H; Ichihashi K
Pediatr Int; 2018 Apr; 60(4):383-384. PubMed ID: 29573057
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
